Preliminary Evidence Shows Strep Vaccine is Safe

"A recombinant hexavalent M protein vaccine against group A streptococcus (GAS) evokes type-specific antibodies against multiple serotypes of GAS in healthy adults, without eliciting antibodies having host tissue cross-reactivity, according to the results of a preliminary phase I trial published in the Aug. 11 issue of JAMA."